RDY 399 (Lansoprazole delayed release 30 mg)
Pill imprint RDY 399 has been identified as Lansoprazole delayed release 30 mg.
Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RDY 399
- 30 mg
- Pink / Black
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
ferric oxide red
ferric oxide yellow
sodium lauryl sulfate
More about lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.